Identity
- Trade Name
- Amplivox FDA UDI
- Generic Name
- Impedance audiometer FDA UDI
- Model / Reference
- Otowave 302 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 05060488901386 FDA UDI
- 510(k) Number
- K171265 FDA UDI
- FDA Product Code
- ETY FDA UDINAS FDA UDI
- GMDN Term
- Impedance audiometer FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 874.1090 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Impedance audiometer
Amplivox by Amplivox, Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Impedance audiometer.
- GN Otometrics A/S — Natus Medical Denmark ApS · Class II
- Madsen Zodiac PC Clinical, Classic probe — Natus Medical Denmark ApS · Class IIa
- Silicone Ear Tips — Natus Medical Denmark ApS · Class I
- 1096 Madsen Zodiac Quick Check Probe Gen 2 — Natus Medical Denmark ApS · Class IIa
- GN Otometrics A/S — Natus Medical Denmark ApS · Class II
- Welch Allyn, Inc. — Welch Allyn, Inc. · Class II
- VIOLA — INVENTIS SRL · Class II
- Silicone Ear Tips — Natus Medical Denmark ApS · Class I
Cleared under the same submission
K171265 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Amplivox, Ltd.
Sources (1)
- FDA UDI ad5b17bb-4b7e-4083-81c8-f924fc62f674 33 fields · synced Jun 8, 2026